Delivery Order SPE2DB20D2014-SPE2DB23FC68V
Award Date 7/7/23
Potential Completion Date 7/10/23
Potential Value $1.4K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $337.86 to Amerisourcebergen Drug Corporation for 4561558660 SEVELAMER HCL 800 MG TABLET 180S. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the specified pharmaceutical product to a location in Conshohocken, Pennsylvania by July 21, 2023 to support the Defense Logistics Agency's medical supply needs. The parent company, Amerisourcebergen Corporation, will oversee performance through its...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,113.89 to AmerisourceBergen Drug Corp for the supply of Sevelamer HCL 800 mg tablets (180-count) on July 23, 2025, with completion expected by July 24, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $631.78 delivery order against the Defense Logistics Agency's prime vendor contract to provide 4561462497 SEVELAMER CARBONATE 800 MG tablets. The firm fixed price order calls for delivery of 90 tablets to a location in Conshohocken, Pennsylvania, with performance required between July 11-12, 2023. No set aside designation or subcontracting details were provided. The Defense Logistics Agency...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,347,314 units of Sevelamer Carbonate 800 mg tablets. The $1,728.00 order, placed under an indefinite delivery contract, is for the delivery of the pharmaceutical product to a performance location in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp, a for-profit organization, has previously received numerous federal...
- The Defense Logistics Agency awarded a $252,240 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561492093 SEVELAMER 0.8 GM POWDER PACKET 90S. The prime contractor, Amerisourcebergen Drug Corporation Corporate Office Division, will deliver the pharmaceutical product from its place of performance in Conshohocken, Pennsylvania under a one day period of performance between July 13-14, 2023. No major subcontractors or set aside designations were indicated. The Defense...
- The Defense Logistics Agency awarded a $10,318 firm fixed price delivery order to AmerisourceBergen Drug Corporation for 180 tablets of 800 mg sevelamer hydrochloride to be delivered to its Conshohocken, Pennsylvania facility by June 30, 2023. As a major pharmaceutical distributor, AmerisourceBergen will fulfill this order to support the Defense Logistics Agency's medical supply needs under its Indefinite Delivery Vehicle contracts. No set aside designation or subcontractors were identified...
- This contract award to AmerisourceBergen Drug Corp's Corporate Office Division provides for the delivery of sevelamer carbonate 800 mg tablets to the Department of Defense's Medical Supply Chain (DLA Troop Support Medical). The $2,192.13 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract valued at up to $999,999,999 through December 2025 for pharmaceutical and medical supplies. This contract does not have a set-aside designation. AmerisourceBergen, one of the...
- The U.S. Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Sevelamer Carbonate 800 mg tablets (270-count). This is a firm fixed-price delivery order with a ceiling value of $5,849.30, with an ultimate completion date of August 21, 2025. The contract represents a non-competitive, non-set-aside award, and the place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $7,550.32 firm fixed-price delivery order is for the supply of sevelamer hydrochloride 800 mg tablets, a medication used to treat certain kidney conditions. The contract has an ultimate completion date of March 10, 2022 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,438.91, is for the delivery of sevelamer carbonate 800 mg tablets. It is a firm fixed-price delivery order with a completion date of January 3, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also registered as a for-profit organization in the System for Award Management...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB23FC68VDelivery Order
The Defense Logistics Agency awarded a $1,449.94 firm fixed price delivery order to Amerisourcebergen Drug Corp for the supply of 4561437223 SEVELAMER HCL 800 MG TABLET 180S. As the prime contractor, Amerisourcebergen Drug Corp will deliver the pharmaceutical products from its facility in Conshohocken, Pennsylvania to fulfill DLA's requirements. Amerisourcebergen Drug Corp is a division of Amerisourcebergen Corporation, a major pharmaceutical distributor supporting DLA's medical logistics programs. The delivery order, which runs from July 7-10, 2023, was issued against an existing DLA-wide supply chain contract vehicle but carries no set aside designation for small businesses.
Generated 12/24/23, 10:21 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 7/7/23 |